We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$53.1B
AUM Growth
+$4.7B
(+9.7%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
2,495
New
186
Increased
937
Reduced
1,188
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Supernus Pharmaceuticals
SUPN
$2.78B
| $504K | ﹤0.01% |
17,425
+4,129
| +31% | +$109K |
|
1877
Fluence Energy
FLNC
$2.43B
| $504K | ﹤0.01% |
21,141
-3,480
| -14% | -$73.3K |
|
1878
Carriage Services
CSV
$543M
| $503K | ﹤0.01% |
20,108
-3,271
| -14% | -$77K |
|
|
GDEN
1879
DELISTED
Golden Entertainment
GDEN
| $501K | ﹤0.01% |
12,556
-3,624
| -22% | -$131K |
|
1880
Prothena Corp
PRTA
$468M
| $501K | ﹤0.01% |
13,781
-4,728
| -26% | -$182K |
|
1881
Howard Hughes
HHH
$4B
| $498K | ﹤0.01% |
6,108
+2,148
| +54% | +$151K |
|
1882
Transmedics
TMDX
$3.04B
| $497K | ﹤0.01% |
6,303
+223
| +4% | +$13.5K |
|
1883
MasTec
MTZ
$22.1B
| $497K | ﹤0.01% |
6,567
-1,108
| -14% | -$69.3K |
|
1884
Glacier Bancorp
GBCI
$6.36B
| $496K | ﹤0.01% |
11,996
-22,954
| -66% | -$781K |
|
|
DOOR
1885
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $494K | ﹤0.01% |
+5,835
| New | +$505K |
|
1886
Opko Health
OPK
$1.02B
| $493K | ﹤0.01% |
326,655
+151,025
| +86% | +$218K |
|
1887
Vital Farms
VITL
$503M
| $489K | ﹤0.01% |
31,183
-50,308
| -62% | -$636K |
|
1888
Gibraltar Industries
ROCK
$1.46B
| $489K | ﹤0.01% |
6,188
+1,081
| +21% | +$73.9K |
|
1889
PMV Pharmaceuticals
PMVP
$69.3M
| $489K | ﹤0.01% |
157,645
+143,034
| +979% | +$378K |
|
|
CADE
1890
DELISTED
Cadence Bank
CADE
| $488K | ﹤0.01% |
16,499
+5,145
| +45% | +$126K |
|
1891
Astronics
ATRO
$3.72B
| $488K | ﹤0.01% |
33,611
+20,766
| +162% | +$272K |
|
|
AHT
1892
Ashford Hospitality Trust
AHT
$20.8M
| $485K | ﹤0.01% |
25,011
-41,910
| -63% | -$923K |
|
1893
Protolabs
PRLB
$2.18B
| $485K | ﹤0.01% |
12,446
-37,328
| -75% | -$1.21M |
|
1894
NRC Health Common Stock
NRC
$468M
| $484K | ﹤0.01% |
12,238
-17,493
| -59% | -$732K |
|
1895
Phillips Edison & Co
PECO
$5.1B
| $484K | ﹤0.01% |
13,267
-1,536
| -10% | -$53.7K |
|
1896
Piper Sandler
PIPR
$5.35B
| $483K | ﹤0.01% |
11,040
-3,836
| -26% | -$146K |
|
1897
Urban Edge Properties
UE
$2.75B
| $480K | ﹤0.01% |
26,246
-4,944
| -16% | -$81.5K |
|
1898
Joby Aviation
JOBY
$8.56B
| $480K | ﹤0.01% |
72,167
-1,597
| -2% | -$9.84K |
|
1899
Clover Health Investments
CLOV
$2.35B
| $478K | ﹤0.01% |
502,022
-286,390
| -36% | -$281K |
|
1900
World Acceptance Corp
WRLD
$875M
| $478K | ﹤0.01% |
3,661
+1,653
| +82% | +$194K |
|
Similar funds
VGA
AQR Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Capital Management held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- AQR Capital Management added most to Amazon in Q4 2023, an estimated $144M increase.
- AQR Capital Management's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- AQR Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- AQR Capital Management's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- AQR Capital Management opened 186 new positions and closed 172 in Q4 2023.
- AQR Capital Management's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.